BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9175907)

  • 21. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D; Wofsy D; Imboden JB
    J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of co-stimulation in airway inflammation.
    Djukanovic R
    Clin Exp Allergy; 2000 Jun; 30 Suppl 1():46-50. PubMed ID: 10849475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of CTLA-4 as an immune attenuator.
    Thompson CB; Allison JP
    Immunity; 1997 Oct; 7(4):445-50. PubMed ID: 9354465
    [No Abstract]   [Full Text] [Related]  

  • 25. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway.
    Tzianabos AO; Chandraker A; Kalka-Moll W; Stingele F; Dong VM; Finberg RW; Peach R; Sayegh MH
    Infect Immun; 2000 Dec; 68(12):6650-5. PubMed ID: 11083777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness.
    Tsuyuki S; Tsuyuki J; Einsle K; Kopf M; Coyle AJ
    J Exp Med; 1997 May; 185(9):1671-9. PubMed ID: 9151904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.
    Zheng Y; Manzotti CN; Liu M; Burke F; Mead KI; Sansom DM
    J Immunol; 2004 Mar; 172(5):2778-84. PubMed ID: 14978077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 30. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.
    Buhlmann JE; Elkin SK; Sharpe AH
    J Immunol; 2003 Jun; 170(11):5421-8. PubMed ID: 12759417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

  • 33. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF; Allison JP
    J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative co-receptors on lymphocytes.
    Greenwald RJ; Latchman YE; Sharpe AH
    Curr Opin Immunol; 2002 Jun; 14(3):391-6. PubMed ID: 11973140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
    Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
    Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
    Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
    [No Abstract]   [Full Text] [Related]  

  • 38. Costimulatory wars: the tumor menace.
    Hurwitz AA; Kwon ED; van Elsas A
    Curr Opin Immunol; 2000 Oct; 12(5):589-96. PubMed ID: 11007364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes.
    Liu SZ; Jin SZ; Liu XD; Sun YM
    BMC Immunol; 2001; 2():8. PubMed ID: 11532194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
    Metzler WJ; Bajorath J; Fenderson W; Shaw SY; Constantine KL; Naemura J; Leytze G; Peach RJ; Lavoie TB; Mueller L; Linsley PS
    Nat Struct Biol; 1997 Jul; 4(7):527-31. PubMed ID: 9228944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.